Status:

UNKNOWN

A Randomized Phase III Study Comparing POF With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer

Lead Sponsor:

Fujian Cancer Hospital

Conditions:

Gastric Cancer Stage III

Eligibility:

All Genders

18-70 years

Phase:

PHASE3

Brief Summary

FNF-014 is a randomised, open-label, multicentre, parallel-group, phase 3 study in China to prove superiority of POF over S-1/docetaxel in postoperative adjuvant setting for pStage III gastric adenoca...

Eligibility Criteria

Inclusion

  • Age 18 to 70 years.
  • Histologically proven in gastric adenocarcinoma (including adenocarcinoma of the gastrooesophageal junction) of stage IIIA, IIIB, IIIC with no evidence of metastatic disease.
  • Subjects must be able to take orally.
  • R0 resection with D2 lymph-node dissection with al least 15 lymph nodes were examined to ensure adequate disease classification.
  • Previously untreated except for the initial gastric resection for the primary lesion.
  • ECOG performance status ≦ 1.
  • Able to start chemotherapy with 42 days after gastrectomy.
  • Hgb ≧ 9 g/dL, WBC 4000-12000/mm3, platelets ≧ 100,000/mm3
  • Creatine ≦ upper normal limit (UNL)
  • Total bilirubin ≦ 1.5 X UNL
  • AST, ALT and ALP ≦ 2.5 x UNL
  • Life expectancy estimated than 3 months
  • Written informed consent

Exclusion

  • Active double cancer
  • Gastrointestinal bleeding
  • Pregnancy or lactation women, or women with suspected pregnancy or men with willing to get pregnant
  • Definite contraindications for the use of corticosteroids
  • Any subject judged by the investigator to be unfit for any reason to participate in the study

Key Trial Info

Start Date :

February 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2023

Estimated Enrollment :

600 Patients enrolled

Trial Details

Trial ID

NCT03788226

Start Date

February 1 2019

End Date

December 31 2023

Last Update

October 16 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rongbo Lin

Fuzhou, China, 350014

A Randomized Phase III Study Comparing POF With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer | DecenTrialz